Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1995 Feb;103(2):156–160. doi: 10.1289/ehp.95103156

Tobacco and cancer: epidemiology and the laboratory.

P Vineis 1, N Caporaso 1
PMCID: PMC1518986  PMID: 7737063

Abstract

Tobacco smoke contains many mutagenic and carcinogenic chemicals. Both whole tobacco smoke and extracts induce tumors in experimental animals. Work with carcinogen-macromolecule adducts provided evidence for the action of specific chemicals. Molecular epidemiology studies suggested that point mutations in tumor-suppressor genes (e.g., p53) and oncogenes (e.g., ras) may be specific both for the type of tumor and for the critical environmental exposure. The consistency among investigations on oncogene/tumor-suppressor gene mutations in lung cancer (and other tobacco-related cancers) in smokers is highly suggestive, although we still lack information about the time sequence between exposure, gene mutation, and cancer onset. Current work that deserves emphasis includes investigations revealing that lungs of smokers contain benzo[a]pyrene diol-epoxide-guanine DNA adducts, which are in accordance with the type of mutations found in K-ras or p53 genes (G to T transversions). In addition, DNA in human exfoliated bladder cells showed a derivative of 4-aminobiphenyl as a main adduct; there was also an association between smoking habits (amount and type of tobacco) and the levels of both DNA adducts and hemoglobin adducts formed by aromatic amines. Increasing evidence indicates that genetically based metabolic polymorphisms exert a role in modulating individual susceptibility to the action of tobacco carcinogens. Overall, the weight of evidence strongly supports the causal nature of the association between smoking and cancer and falsifies Fisher's hypothesis that the association was due to confounding by genetic predisposition.

Full text

PDF
156

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amos C. I., Caporaso N. E., Weston A. Host factors in lung cancer risk: a review of interdisciplinary studies. Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct;1(6):505–513. [PubMed] [Google Scholar]
  2. Auerbach O., Hammond E. C., Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. N Engl J Med. 1979 Feb 22;300(8):381–385. doi: 10.1056/NEJM197902223000801. [DOI] [PubMed] [Google Scholar]
  3. Balmain A., Brown K., Akhurst R. J., Fee F. M. Molecular analysis of chemical carcinogenesis in the skin. Br J Cancer Suppl. 1988 Dec;9:72–75. [PMC free article] [PubMed] [Google Scholar]
  4. Bartsch H., Malaveille C., Friesen M., Kadlubar F. F., Vineis P. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer. 1993;29A(8):1199–1207. doi: 10.1016/s0959-8049(05)80315-6. [DOI] [PubMed] [Google Scholar]
  5. Begg C. B., Zhang Z. F. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev. 1994 Mar;3(2):173–175. [PubMed] [Google Scholar]
  6. Bell D. A., Taylor J. A., Paulson D. F., Robertson C. N., Mohler J. L., Lucier G. W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst. 1993 Jul 21;85(14):1159–1164. doi: 10.1093/jnci/85.14.1159. [DOI] [PubMed] [Google Scholar]
  7. Boffetta P. Black (air-cured) and blond (flue-cured) tobacco and cancer risk. V: Oral cavity cancer. Eur J Cancer. 1993;29A(9):1331–1335. doi: 10.1016/0959-8049(93)90086-u. [DOI] [PubMed] [Google Scholar]
  8. Braun M. M., Caporaso N. E., Page W. F., Hoover R. N. Genetic component of lung cancer: cohort study of twins. Lancet. 1994 Aug 13;344(8920):440–443. doi: 10.1016/s0140-6736(94)91770-1. [DOI] [PubMed] [Google Scholar]
  9. Caporaso N., Landi M. T., Vineis P. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics. 1991 Oct;1(1):4–19. doi: 10.1097/00008571-199110000-00003. [DOI] [PubMed] [Google Scholar]
  10. Carmella S. G., Kagan S. S., Kagan M., Foiles P. G., Palladino G., Quart A. M., Quart E., Hecht S. S. Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. Cancer Res. 1990 Sep 1;50(17):5438–5445. [PubMed] [Google Scholar]
  11. Carmelli D., Swan G. E., Robinette D., Fabsitz R. Genetic influence on smoking--a study of male twins. N Engl J Med. 1992 Sep 17;327(12):829–833. doi: 10.1056/NEJM199209173271201. [DOI] [PubMed] [Google Scholar]
  12. Castonguay A., Stoner G. D., Schut H. A., Hecht S. S. Metabolism of tobacco-specific N-nitrosamines by cultured human tissues. Proc Natl Acad Sci U S A. 1983 Nov;80(21):6694–6697. doi: 10.1073/pnas.80.21.6694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cholerton S., Arpanahi A., McCracken N., Boustead C., Taber H., Johnstone E., Leathart J., Daly A. K., Idle J. R. Poor metabolisers of nicotine and CYP2D6 polymorphism. Lancet. 1994 Jan 1;343(8888):62–63. doi: 10.1016/s0140-6736(94)90921-0. [DOI] [PubMed] [Google Scholar]
  14. De Stefani E., Barrios E., Fierro L. Black (air-cured) and blond (flue-cured) tobacco and cancer risk. III: Oesophageal cancer. Eur J Cancer. 1993;29A(5):763–766. doi: 10.1016/s0959-8049(05)80363-6. [DOI] [PubMed] [Google Scholar]
  15. Doll R., Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health. 1978 Dec;32(4):303–313. doi: 10.1136/jech.32.4.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. FISHER R. A. Lung cancer and cigarettes. Nature. 1958 Jul 12;182(4628):108–108. doi: 10.1038/182108a0. [DOI] [PubMed] [Google Scholar]
  17. Field J. K., Spandidos D. A., Malliri A., Gosney J. R., Yiagnisis M., Stell P. M. Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer. 1991 Sep;64(3):573–577. doi: 10.1038/bjc.1991.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Floderus B., Cederlöf R., Friberg L. Smoking and mortality: a 21-year follow-up based on the Swedish Twin Registry. Int J Epidemiol. 1988 Jun;17(2):332–340. doi: 10.1093/ije/17.2.332. [DOI] [PubMed] [Google Scholar]
  19. Habuchi T., Takahashi R., Yamada H., Ogawa O., Kakehi Y., Ogura K., Hamazaki S., Toguchida J., Ishizaki K., Fujita J. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res. 1993 Aug 15;53(16):3795–3799. [PubMed] [Google Scholar]
  20. Hammond S. K., Coghlin J., Gann P. H., Paul M., Taghizadeh K., Skipper P. L., Tannenbaum S. R. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. J Natl Cancer Inst. 1993 Mar 17;85(6):474–478. doi: 10.1093/jnci/85.6.474. [DOI] [PubMed] [Google Scholar]
  21. Harris C. C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res. 1991 Sep 15;51(18 Suppl):5023s–5044s. [PubMed] [Google Scholar]
  22. Hecht S. S., Carmella S. G., Murphy S. E., Akerkar S., Brunnemann K. D., Hoffmann D. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med. 1993 Nov 18;329(21):1543–1546. doi: 10.1056/NEJM199311183292105. [DOI] [PubMed] [Google Scholar]
  23. Heckbert S. R., Weiss N. S., Hornung S. K., Eaton D. L., Motulsky A. G. Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J Natl Cancer Inst. 1992 Mar 18;84(6):414–422. doi: 10.1093/jnci/84.6.414. [DOI] [PubMed] [Google Scholar]
  24. Hegmann K. T., Fraser A. M., Keaney R. P., Moser S. E., Nilasena D. S., Sedlars M., Higham-Gren L., Lyon J. L. The effect of age at smoking initiation on lung cancer risk. Epidemiology. 1993 Sep;4(5):444–448. doi: 10.1097/00001648-199309000-00010. [DOI] [PubMed] [Google Scholar]
  25. Hein D. W. Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta. 1988 Aug 3;948(1):37–66. doi: 10.1016/0304-419x(88)90004-2. [DOI] [PubMed] [Google Scholar]
  26. Hirvonen A., Husgafvel-Pursiainen K., Karjalainen A., Anttila S., Vainio H. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct;1(6):485–489. [PubMed] [Google Scholar]
  27. Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science. 1991 Jul 5;253(5015):49–53. doi: 10.1126/science.1905840. [DOI] [PubMed] [Google Scholar]
  28. Husgafvel-Pursiainen K., Hackman P., Ridanpä M., Anttila S., Karjalainen A., Partanen T., Taikina-Aho O., Heikkilä L., Vainio H. K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Int J Cancer. 1993 Jan 21;53(2):250–256. doi: 10.1002/ijc.2910530213. [DOI] [PubMed] [Google Scholar]
  29. Ingelman-Sundberg M., Johansson I., Persson I., Yue Q. Y., Dahl M. L., Bertilsson L., Sjöqvist F. Genetic polymorphism of cytochromes P450: interethnic differences and relationship to incidence of lung cancer. Pharmacogenetics. 1992 Dec;2(6):264–271. doi: 10.1097/00008571-199212000-00004. [DOI] [PubMed] [Google Scholar]
  30. Kobayashi T., Tsuda H., Noguchi M., Hirohashi S., Shimosato Y., Goya T., Hayata Y. Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. Cancer. 1990 Jul 15;66(2):289–294. doi: 10.1002/1097-0142(19900715)66:2<289::aid-cncr2820660216>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  31. Luceri F., Pieraccini G., Moneti G., Dolara P. Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air. Toxicol Ind Health. 1993 May-Jun;9(3):405–413. doi: 10.1177/074823379300900302. [DOI] [PubMed] [Google Scholar]
  32. McMichael A. J. Invited commentary--"molecular epidemiology": new pathway or new travelling companion? Am J Epidemiol. 1994 Jul 1;140(1):1–11. doi: 10.1093/oxfordjournals.aje.a117153. [DOI] [PubMed] [Google Scholar]
  33. Nakachi K., Imai K., Hayashi S., Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 1993 Jul 1;53(13):2994–2999. [PubMed] [Google Scholar]
  34. Nazar-Stewart V., Motulsky A. G., Eaton D. L., White E., Hornung S. K., Leng Z. T., Stapleton P., Weiss N. S. The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res. 1993 May 15;53(10 Suppl):2313–2318. [PubMed] [Google Scholar]
  35. Prehn R. T. Cancers beget mutations versus mutations beget cancers. Cancer Res. 1994 Oct 15;54(20):5296–5300. [PubMed] [Google Scholar]
  36. Randerath E., Danna T. F., Randerath K. DNA damage induced by cigarette smoke condensate in vitro as assayed by 32P-postlabeling. Comparison with cigarette smoke-associated DNA adduct profiles in vivo. Mutat Res. 1992 Jul;268(1):139–153. doi: 10.1016/0027-5107(92)90091-f. [DOI] [PubMed] [Google Scholar]
  37. Rivenson A., Hoffmann D., Prokopczyk B., Amin S., Hecht S. S. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 1988 Dec 1;48(23):6912–6917. [PubMed] [Google Scholar]
  38. Sancho-Garnier H., Theobald S. Black (air-cured) and blond (flue-cured) tobacco and cancer risk II: Pharynx and larynx cancer. Eur J Cancer. 1993;29A(2):273–276. doi: 10.1016/0959-8049(93)90192-i. [DOI] [PubMed] [Google Scholar]
  39. Sellers T. A., Bailey-Wilson J. E., Elston R. C., Wilson A. F., Elston G. Z., Ooi W. L., Rothschild H. Evidence for mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst. 1990 Aug 1;82(15):1272–1279. doi: 10.1093/jnci/82.15.1272. [DOI] [PubMed] [Google Scholar]
  40. Shields P. G., Bowman E. D., Harrington A. M., Doan V. T., Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 1993 Aug 1;53(15):3486–3492. [PubMed] [Google Scholar]
  41. Simons A. M., Phillips D. H., Coleman D. V. Damage to DNA in cervical epithelium related to smoking tobacco. BMJ. 1993 May 29;306(6890):1444–1448. doi: 10.1136/bmj.306.6890.1444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Slebos R. J., Hruban R. H., Dalesio O., Mooi W. J., Offerhaus G. J., Rodenhuis S. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst. 1991 Jul 17;83(14):1024–1027. doi: 10.1093/jnci/83.14.1024. [DOI] [PubMed] [Google Scholar]
  43. Soussi T., Legros Y., Lubin R., Ory K., Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer. 1994 Apr 1;57(1):1–9. doi: 10.1002/ijc.2910570102. [DOI] [PubMed] [Google Scholar]
  44. Spruck C. H., 3rd, Rideout W. M., 3rd, Olumi A. F., Ohneseit P. F., Yang A. S., Tsai Y. C., Nichols P. W., Horn T., Hermann G. G., Steven K. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res. 1993 Mar 1;53(5):1162–1166. [PubMed] [Google Scholar]
  45. Suzuki H., Takahashi T., Kuroishi T., Suyama M., Ariyoshi Y., Takahashi T., Ueda R. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res. 1992 Feb 1;52(3):734–736. [PubMed] [Google Scholar]
  46. Taioli E., Kinney P., Zhitkovich A., Fulton H., Voitkun V., Cosma G., Frenkel K., Toniolo P., Garte S., Costa M. Application of reliability models to studies of biomarker validation. Environ Health Perspect. 1994 Mar;102(3):306–309. doi: 10.1289/ehp.94102306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Talaska G., Dooley K. L., Kadlubar F. F. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography. Carcinogenesis. 1990 Apr;11(4):639–646. doi: 10.1093/carcin/11.4.639. [DOI] [PubMed] [Google Scholar]
  48. Talaska G., al-Juburi A. Z., Kadlubar F. F. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5350–5354. doi: 10.1073/pnas.88.12.5350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Vineis P., Bartsch H., Caporaso N., Harrington A. M., Kadlubar F. F., Landi M. T., Malaveille C., Shields P. G., Skipper P., Talaska G. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature. 1994 May 12;369(6476):154–156. doi: 10.1038/369154a0. [DOI] [PubMed] [Google Scholar]
  50. Vineis P., Caporaso N., Tannenbaum S. R., Skipper P. L., Glogowski J., Bartsch H., Coda M., Talaska G., Kadlubar F. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking. Cancer Res. 1990 May 15;50(10):3002–3004. [PubMed] [Google Scholar]
  51. Vineis P. Epidemiological models of carcinogenesis: the example of bladder cancer. Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb;1(2):149–153. [PubMed] [Google Scholar]
  52. Vähäkangas K. H., Samet J. M., Metcalf R. A., Welsh J. A., Bennett W. P., Lane D. P., Harris C. C. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet. 1992 Mar 7;339(8793):576–580. doi: 10.1016/0140-6736(92)90866-2. [DOI] [PubMed] [Google Scholar]
  53. You M., Candrian U., Maronpot R. R., Stoner G. D., Anderson M. W. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci U S A. 1989 May;86(9):3070–3074. doi: 10.1073/pnas.86.9.3070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Zhang Z. F., Sarkis A. S., Cordon-Cardo C., Dalbagni G., Melamed J., Aprikian A., Pollack D., Sheinfeld J., Herr H. W., Fair W. R. Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):19–24. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES